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ABSTRACT 
Background Care.data was a programme of work led by NHS England for the 
extraction of patient-identifiable and coded information from general practitioner GP 
records for secondary uses. This study analyses the forms (on the websites of GP 
practices) which enabled patients to opt out. 
Methods Theoretical sampling and summative content analysis were used to collect 
and analyse dissent forms used by patients to opt out from care.data. Domains 
included basic information about the programme, types of objections and personal 
details required for identification purposes. 
Results One hundred opt out forms were analysed. Fifty-four forms mentioned that 
this programme was run by NHS England. Eighty-one forms provided 2 types of 
objections to data sharing and 15 provided only one objection. Only 26 forms 
mentioned that direct care would not be affected and 32 that patients maintain their 
right to opt back in anytime. All but one of the opt out forms we reviewed requested 
the name of the person wishing to opt out. Ninety-four required a date of birth and 33 
an NHS number. Eighty-two required an address, 42 a telephone number and 7 an 
email address.  
Conclusion Numbers of patients (not) opting out should be treated with caution 
because the variability of information provided and the varied options for dissent may 
have caused confusion among patients. To ensure that dissent is in accordance with 
individual preferences and moral values, we recommend that well-designed 
information material and standardised opt out forms be developed for such data 
sharing initiatives. 
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INTRODUCTION 
Electronic health records (EHRs) are becoming valuable sources of data for public 
health research across large populations. Due to the volume, variety and velocity of 
(long-term follow-up) information, [1] researchers can discover and monitor disease 
and healthcare trends as well as the effectiveness of new interventions and treatments 
with minimum cost. As EHRs are increasingly linked to secondary care and mortality 
datasets, they could provide good information on morbidity and lifestyle, prescribing, 
standards of care and inter-practice variation.[2] They are increasingly used in 
biomedical research, where phenotype-genotype associations can be developed for 
specific diseases and help researchers focus on collecting samples from high-risk 
patients.[3,4] Particularly in England, more than 30 years of coded health data in GP 
information systems is now available that can be used in this kind of research.[5]  
The need for consent for the research use of EHRs has been the focus of ethical 
debate.[6,7] When it comes to the processing of identifiable personal health 
information, there are usually two options available. EHRs can be included in 
research by default unless patients opt out or patients can actively consent to 
participate (opt in). Both approaches are limited in their ability to support informed 
consent, particularly across large populations. For example, consent documents may 
not reach all patients or may not be understood [8,9]. This discourages good decision 
making.[10] However, an opt in approach to consent usually results in lower 
participation and less representative samples of the study population. [8,11–13] For 
low risk, population level studies an opt out or social contract approach may be a 
more valid alternative for expressing consent.[14,15] On the other hand, opting in is 
preferable for the potential participants [16] and it is considered more ethical since it 
requires actual consent, without relying on inertia. This is also understood by patients 
as a token of consent.[17] Consent forms are tangible artefacts of awareness, 
cooperation and trust for participation in research [18] that can “standardise, 
operationalise and verify the process of informed consent”.[19]  
Care.data was a programme of work led by NHS England and the Health and Social 
Care Information Centre (HSCIC) to extract patient identifiable (NHS number, date 
of birth, postcode and gender) and coded (e.g. medical history, vaccinations, 
diagnoses, referrals and NHS prescriptions) information from GP records to a central 
database. These records would have been linked to other NHS records from hospitals, 
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community, mental health and social care services after they have been de-
identified.[20]  Care.data would then be able to help NHS England to ensure better 
and cost-effective services, such as e-prescribing1, while understanding diseases and 
trends in public health, developing and monitoring the safety of drugs and treatments 
and comparing quality care across the country [21].  
The right to opt out was not available to patients from the outset. It was only after an 
Information Governance Review [22] that HSCIC and NHS England committed to 
respecting this decision.[23].  GPs, as data controllers, had a legal responsibility to 
inform their patients about the programme and to register any dissents on their 
records. Two types of objections or opt outs (these terms are used interchangeably in 
this paper) were possible: type 1 (data would not be extracted from the GP record to 
HSCIC) and type 2 (data would not be shared outside of the HSCIC in any 
identifiable form).[24] There was confusion about whether a patient who had 
registered a type 2 objection would continue to receive direct care services, such as e-
referrals and screening.[25] Information about care.data provided to patients through 
leaflets posted to households was later deemed unfit for purpose.[26] It was biased 
towards the benefits of the programme and had little information on how to opt 
out.[27] The British Medical Association (BMA) [28] and GP Committees [29] were 
in favour of an opt in approach. There was no standardised opt out form available for 
patients to submit to their GP practice, unlike the NHS Summary Care Records 
(SCR)2 .  
Care.data was eventually put on hold3 due to old [30] and new concerns, including the 
lack of a code of practice, the technical capabilities of the information technology (IT) 
contractor,  the pseudonymisation technique, consent (opt in vs. opt out), and the cost 
of the  programme. More widely, there were also concerns about data access for 
commercial purposes, public engagement, monitoring and auditing of data release 
contracts, penalties for data misuse, and data security. A central issue which the 
programme never adequately addressed was the public reaction. As of April 2016, 
                                                        
1 http://systems.hscic.gov.uk/eps 
2 http://systems.hscic.gov.uk/scr/library/optout.pdf 
3 These problems that the programme ran into were also considered by a House of 
Commons Health Committee. See: 
http://www.parliament.uk/business/committees/committees-a-z/commons-
select/health-committee/inquiries/parliament-2010/cdd-2014/ 
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around 1 in 45 citizens in England who had registered with a GP Practice had 
expressed a type 2 objection.[31] At the time of the writing of this paper, NHS 
England decided [32] to close the care.data programme (July 6, 2016). 
So far, no study has assessed and compared the content of dissent forms for the use of 
GP records for secondary purposes. The purpose of this paper was to explore the 
content (information provided and the identification details required) of informed 
consent documents designed by GP practices for patients to opt out from care.data. 
METHODS 
There are approximately 8,000 GP practices in England.[33] We sourced opt out 
forms for care.data by searching online and downloading them from the websites of 
individual GP practices. We used the ‘advanced search’ feature of the Google search 
engine to search for “care.data opt out form”, narrowing our results by language 
(English), region (United Kingdom) and file type (Adobe Acrobat PDF).4  
We used theoretical sampling [34] to select a fairly random and also highly variant (in 
terms of content) sample so as to explore the heterogeneity that existed across these 
forms, in the absence of a standardised approach. After retrieving 130 opt out forms, 
we carefully read them and removed any duplicates (forms that were exactly the same 
in terms of design and content, the only difference being the GP practice details). 
Following that, we used summative content analysis [35] to identify, analyse and 
describe the content in the opt out forms. This approach to qualitative content analysis 
was appropriate for a study that explores usage of specific content in textual 
material.[36] After reading these forms several times, we identified our unique units 
of analysis and grouped them under 3, mutually exclusive and exhaustive, categories 
based on their contextual similarity: information about the care.data programme (e.g. 
scope of data collection, organisations involved, patient rights, procedure), options 
available and types of objections to data sharing included, personal details required 
from patients by GP practices for identification purposes (e.g. name, address, 
telephone number) and opportunity to opt out family members. These categories and 
units were then entered into an Excel document for quantifying and sorting their 
presence across the forms. 
                                                        
4 This file format preserves page layout and the exact look of a printed document 
better than other file formats across platforms.    
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While the websites of individual GP practices ( where links to these forms can be 
found) usually provide additional information about care.data  we do not review them 
here. The analysis is focused only on the documents that patients could download, 
print out and take them to their GP practice in order to opt out.  
RESULTS 
We analysed 100 unique opt out forms. The length of these forms ranged from 1 to 6 
pages, with an average length of 1.48 pages. A typical opt out form was usually one 
page long. Longer forms ones provided more details about the programme or 
information about other data sharing schemes, such as SCR.  
Programme information 
All but one of the opt out forms clearly noted that they were related to care.data with 
the name appearing somewhere on the form. Eighty-four forms informed their 
patients that it was the HSCIC collecting data from their records, but only 54 
mentioned that this programme was related to (or had the logo of) NHS England on 
the form. Half of the reviewed forms provided more information related to this 
programme and/or pointed to the leaflet ('Better Information Means Better Care') 
released by NHS England or provided links to the relevant website5 so that patients 
could find more details about the programme. Typically, where additional information 
was provided about the programme it included the start date, aims (planning and 
monitoring of patient services), possible approved releases of identifiable information, 
security guarantees, types of organisations with potential access to this data (NHS and 
private), the importance of data sharing and the options available regarding 
objections. One form mentioned that care.data had the support of the British Medical 
Association (BMA).  
Lastly, 31 forms clearly explained that this programme was not related to SCR and 
that patients would have to fill in another form if they wished to opt out. Only 32 
forms expressly informed patients that they maintained their right to opt back in 
anytime should they change their mind. Also, only 26 forms expressly mentioned the 
fact that their direct care would not be affected in any way due to their decision to opt 
                                                        
5 www.nhs.uk/caredata 
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out from care.data, while only 1 form gave patients the opportunity to opt back in by 
providing the relevant tick box. 
Opt out options 
In general, the vast majority of forms (n=81) from GP practices reviewed in this paper 
provided patients with two options to declare their objection – type 1: data would not 
be extracted from the GP record to HSCIC and type 2: data would not be released by 
HSCIC to other parties, outside the NHS, in any identifiable form. 4 forms provided 3 
options, with the 3rd one acting as a confirmation that patients would have liked to opt 
out from both types of data sharing. In these cases, patients had to tick the relevant 
box next to the type of objection they would have liked to exercise. Fifteen forms 
provided only 1 option, which led patients to opt out from care.data altogether, 
without being able to decide which of the two types of GP record releases they would 
have liked to opt out from. 
We were able to identify 42-45 unique wordings for each of the 2 main types of 
objections. We group and list the 5 most commonly used (see tables 1 and 2) and also 
some common examples of only 1 (combined) type of objection to care.data (see table 
3). For the type 1 objection GP practices usually referred to data extracted as either 
‘personal confidential data (PCD)’, ‘GP record’ or ‘identifiable information’, while 
emphasising that data would not be released/leave the GP practice or shared with the 
HSCIC. Some GP practices also referred to care.data as either a system or a 
programme. With the exception of ‘GP record’, the same terms regarding patient 
information were used for the type 2 objection, while emphasising that data would not 
leave the HSCIC – for care.data or any other purpose. In fact, some of these forms 
specifically explained that opting out meant that any data about the patient from any 
NHS source would not have left the HSCIC for any purpose. A greater variation of 
wording was observed among the opt out forms that only offered one opt out 
possibility. There were forms with which patients could simply opt out from 
care.data, forms that focused on explaining that any data (linked to the patient’s NHS 
number) would not be disclosed to HSCIC and forms that clarified that data would 
only be used for direct (medical) care purposes and shared only in exceptional 
circumstances, as required by law.   
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Number 
of Forms 
Phrases taken from opt out forms 
7 
I do not want my GP to release any of my GP record to the HSCIC for 
purposes of the care.data system 
6 
I do not want my personal confidential data to be released by my GP 
surgery for the care.data programme 
6 I do not want my personal confidential data to leave my GP Practice 
5 
I do not want my medical practice to share any identifiable information 
about me with the HSCIC 
5 
I wish to prevent my personal confidential data from leaving the GP 
practice 
Table 1: Most frequent type 1 objections 
 
Number 
of Forms 
Phrases taken from opt out forms 
8 
I am happy for identifiable information about me to be shared with the 
HSCIC for use within the NHS but I do not consent (to identifiable) 
information about me being passed on to any other organisation or third 
party for any purpose 
6 
I do not want my personal confidential data from hospitals and other 
care providers to be released by the HSCIC for the care.data programme 
6 
I do not want the HSCIC to disclose to any accredited third parties any 
information they hold on me (from any NHS source) 
5 I do not want my personal confidential data to leave the HSCIC 
4 
I wish to prevent (my) personal confidential data leaving the HSCIC 
(for purposes other than direct care) 
Table 2: Most frequent type 2 objections 
 
 8 
I confirm that I do not want my confidential information being shared or used for any 
purpose other than providing me with care, except in exceptional circumstances 
I wish to opt out of the care.data data sharing 
I wish to implement my constitutional right to object to the disclosure of my PCD 
from [name of GP Practice] to the HSCIC 
I wish to exercise my right to prevent the extraction of personal care data about me 
linked to my NHS Number both from the practice to the HSCIC and any data 
collected linked to my NHS Number from other sources held by HSCIC to any other 
body or organisation 
I am writing to give notice that I refuse consent for my identifiable information and 
the identifiable information of those for whom I am responsible to be transferred 
from your practice systems for any purpose other than our medical care. Please take 
whatever steps necessary to ensure my confidential personal information is not 
uploaded and record my dissent by whatever means possible.  
Table 3: Common examples of combined types of objections 
 
Moreover, 58 forms also provided the relevant opt out codes to be added in the GP 
record, 19 provided the option to also opt out of the SCR programme or other local 
data sharing schemes (e.g. Hampshire Health Record) and 62 of the forms provided 
the opportunity for someone to opt out not only themselves, but also their family 
members. None of the forms had any information on whether or how patients would 
be notified that their decision had been recorded in their GP record.    
Identification details 
In examining the opt out forms, we identified a variety of details that each practice 
requested in order to identify their patients and respect their wishes. All but one of the 
opt out forms we reviewed requested the name of the person wishing to opt out. 
Ninety-one required a signature and 78 the date it was signed. Ninety-four required a 
date of birth and 33 their NHS number (if known). Eighty-two required an address, 42 
a telephone number, which could be a mobile one, and 7 an email address. One opt 
out form asked for the name of the ‘usual GP’ to be included.  
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DISCUSSION 
In this article, we analysed the opt out forms for the care.data programme by NHS 
England. We have documented how GP practices developed their own informed 
consent material to record patients’ objections to the release of their confidential 
information to HSCIC for secondary uses. The lack of a standardised approach to 
communication and informed consent has resulted in variable ways of recording 
patients’ dissent from the programme. 
In practical terms, the care.data roll-out and the presumed consent model adopted 
proved to be problematic in raising awareness of the programme and the right of 
patients to opt out.[37] This broad opt out approach with two types of objections has 
been deemed precarious as it makes it hard for patients to distinguish between what 
they consider to be (un)acceptable secondary uses of their data.[38] Individual 
autonomy and rational decision-making in research requires more than just a simple 
opt out form. Potential participants adopt a relational behaviour based on which 
researcher or institution is approaching them for recruitment and for what 
purposes.[39] They would like to be able to decide between their data being used for 
research purposes in, for example, the academic or commercial sectors.[40]  
Initially, patients could not opt out of care.data at all.[41] The programme has been 
criticised for its inadequate approach in explaining clearly the benefits of the 
programme, as well as the safeguards in place for the protection of individual patient 
data, such as techniques for the removal of personal identifiers, physical security 
measures and oversight mechanisms.[42] In contrast to the leaflet provided by NHS 
England, most of the opt out forms examined in this study mentioned that data 
extraction is for care.data. However, in many of these forms, patients were not even 
informed that their data might continue to be extracted and used by HSCIC, for 
example, in civil emergencies. As these data extractions never actually materialised in 
this programme, GPs were also not in a position to notify patients that their opt out 
had been respected and that they would have participated in this data sharing scheme 
according to their declared type(s) of objection. Due to the limited resources 
available, HSCIC was unable to process the growing number of opt outs. At the same 
time, HSCIC was working out how a type 2 objection could be implemented without 
affecting patient care and screening programmes that rely on data sharing, such as e-
prescribing, bowel cancer screening and e-referrals.[43]  
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There was a lack of adequate technical preparation, public awareness and consultation 
about the benefits and risks of care.data. Its dependence on GPs to inform their 
patients about the programme (without adequate support) might have been seen as a 
way to secure maximum public buy-in by relying on either individual patient inertia 
or by using confusing and cumbersome opt out procedures.[41] It transferred 
responsibility to patients to seek out other sources of information in order to find out 
whether and how they would opt out.[44] This was partially evident in this study. 
When using the Google search engine the first form that someone could download to 
opt out was created by ‘medConfidential’: an independent group campaigning for 
confidentiality and consent in health and social care.[45] Moreover, including all data 
sharing schemes in the same opt out form may also have been unsuitable for patients 
who would have liked to only opt out from one particular scheme. For example, 
patients who may have been frustrated with the data sharing arrangements of one 
scheme might have easily been driven to opt out from other schemes, such as SCR. 
Such misinformed responses, facilitated by an all-inclusive form, may have 
inadvertently affected their direct care in unpredictable ways.     
One limitation of our study is that we did not examine the websites of individual GP 
practices where patients might have found more information about the care.data 
programme of work, to help them make a decision based on their data sharing 
preferences. Also, our study was limited in examining whether specific items 
appeared uniformly across the various opt out forms. Lastly, while there are 
thousands of GP practices across England, we only examined 100 opt out forms. The 
sample, although small, is, we believe, of adequate size to highlight the variability of 
content included in these forms. 
Our intention was not to ‘name and shame’ individual GP practices about their opt out 
forms and how they approached issues of informed consent around the records they 
keep for patients and the data they share. We aimed at revealing the heterogeneity of 
opt out forms that can be found online, particularly with regards to wordings, choices 
and information provided; the result of healthcare professionals and patients 
attempting to make sense of conflicting, misguided and often inadequate information 
about the programme and the opt out procedure from the HSCIC and NHS England. 
As we were examining these opt out forms, we could see how it would be difficult for 
patients to have sufficient information for rational decision-making with regards to 
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their data being shared for secondary purposes. Some forms appeared to be worded in 
a more sympathetic tone towards care.data, others emphasised more the nature of the 
data to be shared (personal confidential) and others were very simple or 
straightforward without providing much information on what an opt out/in actually 
meant for them and their family members.     
We believe that this study demonstrates the various design problems of this 
programme and its lack of attention to the subtleties and sensitivities of healthcare 
professionals and patients who co-produce this data for direct healthcare, and not for 
other secondary purposes. It is important for national big data initiatives to develop 
well-designed information material and standardised approaches to opt out (or opt in 
for that matter) in order to overcome the issues of informed consent that are of 
paramount in the attempt to maintain patient privacy and confidentiality, while 
facilitating sophisticated research from electronic patient records. Hopefully, the 
National Data Guardian’s latest review of health and social data use [46] and her 
recommendations on testing various consent and opt-out options with the public 
before a decision, might give a successor programme to care.data a better chance of 
success. Until then, any actual or speculative numbers of patients (not) opting out 
should be treated with caution by policy and law makers as they attempt to translate 
them into individual preferences and moral values.  
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